Role of topical application of gentamicin containing collagen implants in cardiac surgery

Journal of Cardiothoracic Surgery - Tập 9 - Trang 1-11 - 2014
Pankaj Kumar Mishra1, Ahmed Ashoub2, Kareem Salhiyyah2, Dincer Aktuerk1, Sunil Ohri2, Shahzad G Raja3, Heyman Luckraz1
1Cardiothoracic Unit, Heart and Lung Centre, Wolverhampton, UK
2Wessex Cardiothoracic Centre, Southampton, UK
3Harefield Hospital, London, UK

Tóm tắt

Sternal wound infections (SWI) continue to be a major cause of concern after cardiac surgery. It leads to prolonged hospital stay and increased morbidity, mortality and increased hospital costs. Prophylactic systemic antibiotics have been used to prevent surgical site infection (SSI). However, prolonged postoperative use of systemic antibiotics can lead to emergence of resistant organisms. Gentamycin Containing Collagen Implants (GCCI) when used during sternotomy closure produces high local antibiotic concentrations in the wound with a low serum concentration. There is evidence that the concentration of gentamicin in the mediastinal fluid reaches levels high enough to be effective against bacteria that are considered resistant to gentamycin and other antibiotics. However, questions have been raised about the safety and efficacy of GCCI. There were concerns whether GCCI can lead to systemic absorption with renal impairment and whether use of topical antibiotics can lead to emergence of antimicrobial resistance. We, hereby, review the literature on GCCI (Collatamp) and take the opportunity to appraise the scientific community about their role in cardiac surgery. Several recent studies have supported their clinical effectiveness. They should be used in dry condition and should not be soaked in saline even for a short period prior to use. However, for GCCI to become part of routine practice in cardiac surgery further large randomised studies are required. As the incidence of sternal wound infection is low in the specialty of cardiac surgery, for any study to be sufficiently powered to address this issue, multicenter studies might be the way forward. Based on the evidence presented in this manuscript it is recommended GCCI (Collatamp) can be a cost effective adjunct for prevention of sternal wound infection. They can also be used for treatment of Deep Sternal Wound Infection.

Tài liệu tham khảo

Godbole G, Pai V, Kolvekar S, Wilson A: Use of gentamicin-collagen sponges in closure of sternal wounds in cardiothoracic surgery to reduce wound infections. Interact Cardiovasc Thorac Surg. 2012, 14 (4): 390-394. April Friberg O, Svedjeholm R, Soderquist B, Granfeldt H, Vikerfors T, Kallman J: Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg. 2005, 79: 153-161. Mossad SB, Serkey JM, Longworth DL, Cosgrove DM, Gordon SM: Coagulase-negative staphylococcal sternal wound infections after open heart operations. Ann Thorac Surg. 1997, 63: 395-401. Tegnell A, Aren C, Ohman L: Coagulase-negative staphylococci and sternal infections after cardiac operation. Ann Thorac Surg. 2000, 69: 1104-1109. Hall RE, Ash AS, Ghali WA, Moskowitz MA: Hospital cost of complications associated with coronary artery bypass graft surgery. Am J Cardiol. 1997, 79: 1680-1682. Taylor GJ, Mikell FL, Moses HW: Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol. 1990, 65: 309-313. Eklund AM, Valtonen M, Werkkala KA: Prophylaxis of sternal wound infections with gentamicin–collagen implant: randomized control study in cardiac surgery. J Hosp Infect. 2005, 59: 108-112. Stemberger A, Grimm H, Bader F, Rahn HD, Ascherl R: Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg. 1997, 578 (Suppl): 17-26. Rutten HJ, Nijhuis PH: Prevention of wound infection in elective colorectal surgery by local application of a gentamicin-containing collagen sponge. Eur J Surg. 1997, 578 (Suppl): 31-35. Friberg O, Jones I, Sjoberg L, Soderquist B, Vikerfors T, Kallman J: Antibiotic concentrations in serum and wound fluid after local gentamicin or intravenous dicloxacillin prophylaxis in cardiac surgery. Scand J Infect Dis. 2003, 35: 251-254. Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA: Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob. 2004, 3: 7- Creanor S, Barton A, Marchbank A: Effectiveness of a gentamicin impregnated collagen sponge on reducing sternal wound infections following cardiac surgery: a meta-analysis of randomised controlled trials. Ann R Coll Surg Engl. 2012, 94 (4): 227-231(5). Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR: Guideline for prevention of surgical site infection, 1999 (Hospital Infection Control Practices Advisory Committee). Infect Control Hosp Epidemiol. 1999, 20: 250-278. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008, 36 (5): 309-332. doi: 10.1016/j.ajic.2008.03.002 Surgical site infection: full guideline. National Institute for Health and Clinical Excellence. 2008, SBN 978-1-904752-69-1. (Updated 2013) https://www.evidence.nhs.uk/evidence-update-43 http://www.nice.org.uk/nicemedia/pdf/CG74FullGuideline.pdf Wilson AP, Treasure T, Sturridge MF, Gruneberg RN: A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet. 1986, 1: 311-313. Luckraz H, Treasure T: Infections in cardiac surgery. Surg Infect. 1996, 4: 1-4. Franco S, Herrera AM, Atehortúa M, Vélez L, Botero J, Jaramillo JS, Vélez JF, Fernández H: Use of steel bands in sternotomy closure: implications in high-risk cardiac surgical population. Interact Cardiovasc Thorac Surg. 2009, 8 (2): 200-5. doi: 10.1510/icvts.2008.188136. Epub 2008 Nov 27 DiPiro JT, Martindale RG, Bakst A, Vacani PF, Watson P, Miller MT: Infection in surgical patients: effects on mortality, hospitalization, and post discharge care. Am J Health Syst Pharm. 1998, 55: 777-781. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L: Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. JAMA. 1992, 267: 2344-2348. Farinas MC, Gald Peralta F, Bernal JM, Revuelta JM, Gonzalez-Macias J: Suppurative mediastinitis after open-heart surgery: a case–control study covering a seven-year period in Santander, Spain. Clin Infect Dis. 1995, 20: 272-279. Valla J, Corbineau H, Langanay T: Mediastinitis after cardiac surgery. A 10-year evaluation (1985–1995). Ann Cardiol Angeiol. 1996, 45: 369-376. Luckraz H, Murphy F, Bryant S, Charman SC, Ritchie AJ: Vacuum-assisted closure as a treatment modality for infections after cardiac surgery. J Thorac Cardiovasc Surg. 2003, 125 (2): 301-305. Feb Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori GT: CDC definitions of nosocomial surgical site infections. Infect Control Hosp Epidemiol. 1992, 13: 606-608. Ottino G, De Paulis R, Pansini S: Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. Ann Thorac Surg. 1987, 44: 173-179. Bitkover CY, Gårdlund B: Mediastinitis after cardiovascular operations: a case–control study of risk factors. Ann Thorac Surg. 1998, 65: 36-40. Kreter B, Woods M: Antibiotic prophylaxis for cardiothoracic operations: Meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg. 1992, 104: 590-599. Schersten H: Modified prophylaxis for preventing deep sternal wound infection after cardiac surgery. APMIS. 2007, 11: 1025-1028. The Parisian Mediastinitis Study Group: Risk factors for deep sternal wound infection after sternotomy: a prospective, multicenter study. J Thorac Cardiovasc Surg. 1996, 11: 1200-1207. Hashimoto I, Takaku M, Matsuo S, Abe Y, Harada H, Nagae H, Fujioka Y, Anraku K, Inagawa K, Nakanishi H: Risk factors for complications after reconstructive surgery for sternal wound infection. Arch Plast Surg. 2014, 41 (3): 253-257. doi: 10.5999/aps.2014.41.3.253. Epub 2014 May 12 Hammermeister KE, Burchfiel CR, Grover FL: Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation. 1990, 82 (Suppl. 5): IV380-IV389. Milano CA, Kesler K, Archibald N, Sexton DJ, Jones RH: Mediastinitis after coronary artery bypass graft surgery. Circulation. 1995, 92: 2245-2251. Friberg O, Dahlin LG, Kallman J, Kihlstrom E, Soderquist B, Svedjeholm R: Collagen–gentamicin implant for prevention of sternal wound infection; long-term follow-up of effectiveness. Interact Cardivasc Thorac Surg. 2009, 9: 454-458. Friedrich B, Klaue P, Worlock P, Slack R, Harvey L, Mawhinney R, Koury M, Ellis E: Mechanical stability and post-traumatic osteitis: an experimental evaluation of the relation between infection of bone and internal fixation. Injury. 1977, 9: 23-29. Stahle E, Tammelin A, Bergstrom R, Hambreus A, Nystrom SO, Hansson HE: Sternal wound complications–incidence, microbiology and risk factors. Eur J Cardiothorac Surg. 1997, 11: 1146-1153. Gardlund B, Bitkover CY, Vaage J: Postoperative mediastinitis in cardiac surgery – microbiology and pathogenesis. Eur J Cardiothorac Surg. 2002, 21: 825-830. Wilson AP, Gruneberg RN, Treasure T, Sturridge MF: Staphylococcus epidermidis as a cause of postoperative wound infection after cardiac surgery: assessment of pathogenicity by a wound-scoring method. Br J Surg. 1988, 75: 168-170. Darouiche RO: Treatment of infections associated with surgical implants. N Engl J Med. 2004, 350: 1422-1429. Otto M: Molecular basis of Staphylococcus epidermidis infections. Semin Immunopathol. 2012, 34: 201-214. Widerström M, Wiström J, Sjöstedt A, Monsen T: Coagulase-negative staphylococci: update on themolecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis. 2012, 31: 7-20. Beckmann A, Doebler K, Schaefer E, Koetting J, Gastmeier P, Graf K: Sternal surgical site infection prevention - is there any room for improvement?. Eur J Cardiothorac Surg. 2011, 40: 347-351. Lador A, Nasir H, Mansur N, Sharoni E, Biderman P, Leibovici L, Paul M: Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis. J Antimicrob Chemother. 2012, 67: 541-350. Shahzad G: Raja. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection following cardiac surgery. Int J Surg. 2012, 10: S10eS14- Friberg Ö, Dahlin LG, Söderquist B, Källman J, Svedjeholm R: Influence of more than six sternal fixation wires on the incidence of deep sternal wound infection. Thorac Cardiovasc Surg. 2006, 54: 468-473. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA, American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America: Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013, 70 (3): 195-283. doi: 10.2146/ajhp120568 Song F, Glenny AM: Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Br J Surg. 1998, 85: 1232e41- Morita S, Nishisho I, Nomura T, Fukushima Y, Morimoto T, Hiraoka N, Shibata N: The significance of the intraoperative repeated dosing of antimicrobials for preventing surgical wound infection in colorectal surgery. Surg Today. 2005, 35: 732-8. Suehiro T, Hirashita T, Araki S, Matsumata T, Tsutsumi S, Mochiki E, Kato H, Asao T, Kuwano H: Prolonged antibiotic prophylaxis longer than 24 hours does not decrease surgical site infection after elective gastric and colorectal surgery. Hepatogastroenterology. 2008, 55: 1636-9. Jamil H-C: Gentamicin-ixmpregnated collagen sponge for high-risk cardiac surgery patients. Interact Cardiovasc Thorac Surg. 2013, 16 (2): 141-(eComment) Feb Raja SG, Salhiyyah K, Rafiq MU, Felderhof J, Amrani M: Impact of gentamicin-collagen sponge (collatamp) on the incidence of sternal wound infection in high-risk cardiac surgery patients: a propensity score analysis. Heart Surg Forum. 2012, 15: e257-261. Leyh RG, Bartels C, Sievers HH: Adjuvant treatment of deep sternal wound infection with collagenous gentamycin. Ann Thorac Surg. 1999, 68: 1648-1651. Rutten HJ, Nijhuis PH: Prevention of wound infection in elective colorectal surgery by local application of a gentamicin-containing collagen sponge. Eur J Surg Suppl. 1997, 578: 31-35. Stemberger A, Grimm H, Bader F, Rahn HD, Ascherl R: Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg Suppl. 1997, 578: 17-26. Ruszczak Z, Friess W: Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev. 2003, 55: 1679-1698. Chvapil M: Collagen sponge: theory and practice of medical applications. J Biomed Mater Res. 1977, 11: 721-741. Anderson RE, Lukas G, Skullman S, Hugander A: Local administration of antibiotics by gentamicin–collagen sponge does not improve wound healing or reduce recurrence rate after pilonidal excision with primary suture: a prospective randomized controlled trial. World J Surg. 2010, 34: 3042-3048. Buimer MG, Ankersmit MF, Wobbes T, Klinkenbijl JH: Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol Surg. 2008, 34: 224-227. Gruessner U, Clemens M, Pahlplatz PV, Sperling P, Witte J, Rosen HR, Septocoll Study Group: Improvement of perineal wound healing by local administration of gentamicin-impregnated collagen fleeces after abdominoperineal excision of rectal cancer. Am J Surg. 2001, 182: 502-509. Yetim I, Ozkan O, Dervisoglu A, Erzurumlu K, Canbolant E: Effect of gentamicin-absorbed collagen in wound healing in pilonidal sinus surgery: a prospective randomized study. J IntMed Res. 2010, 38: 1029-1033. Lorenzetti OJ, Fortenberry B, Busby E: Influence of microcrystalline collagen in wound healing. II Comparison of several collagen dressings on excised wounds of pigs and rabbits. Res Comm Chem Path Pharm. 1973, 5: 431-440. Reddi AH: Implant stimulated interface reaction during collagenous bone matrix induced bone formation. J Biomed Mater Res. 1985, 19: 233-239. Kadurugamuwa JL, Beveridge TJ: Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosaand the effect of aminoglycoside antibiotics on their release. J Antimicrob Chemother. 1997, 40: 615-621. Moore RD, Smith CR, Lietman PS: The association of aminoglycoside plasma levels with mortality in patients with gram negative bacteremia. J Infect Dis. 1984, 149: 443-448. Moore RD, Lietman PS, Smith CR: Clinical response to aminoglycoside therapy (importance of the ratio of peak concentration to minimal inhibitory concentration). J Infec Dis. 1987, 155: 93-99. Grimm H: Collagen as a drug carrier and its application in surgery. Edited by: Stemberger A, Ascherl R, Lechner F, Blümel G. 1989, Stuttgart, New York: Schattauer, 33-37. 1 Collatamp. Product Information. http://www.eusapharma.com/en-gb/default.aspx, http://www.eusapharma.com/smpc/collatamp/en/SmPC-Portugal-Cronocol-English.pdf Bennett-Guerrero E, Ferguson TB, Lin M, Garg J, Mark DB, Scavo VA, Kouchoukos N, Richardson JB, Pridgen RL, Corey GR, SWIPE-1 Trial Group: Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA. 2010, 304 (307): 755-62. Aug 18 Birgand G, Radu C, Alkhoder S, Al Attar N, Raffoul R, Dilly MP, Nataf P, Lucet JC: Does a gentamicin-impregnated collagen sponge reduce sternal wound infections in high-risk cardiac surgery patients?. Interact Cardiovasc Thorac Surg. 2013, 16 (2): 134-141. Corn T: Treating sternal wound infections after cardiac surgery with an implantable gentamicin–collagen sponge. Letter. J Am Med Assoc. 2010, 304: 2123-doi: 10.1001/jama.2010.1612 Raja SG: The devil is in the detail! Interact Cardiovasc. Thorac Surg. 2013, 16 (2): 141-142. Friberg O: Treating sternal wound infections after cardiac surgery with an implantable gentamicin–collagen sponge—letter. J Am Med Assoc. 2010, 304: 2123-4. doi: 10.1001/jama.2010.1613 Lovering AM, Sunderland J: Impact of soaking gentamicin- containing collagen implants on potential antimicrobial efficacy. Int J Surg. 2012, 10 (Suppl 1): S2-4. Cohen G, Fremes S, Sever J, Moussa GT, Christakis GT, Goldman BS: Mitigation of sternal wound infection by application of a gentamicin impregnated collagen sponge at the time of sternal closure. presented at the Canadian cardiovascular congress. 2010, [Abstract 495] Schimmer C, Ozkur M, Sinha B, Hain J, Gorski A, Hager B, Leyh R: Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: A controlled, prospectively randomized, double-blind study. J Thorac Cardiovasc Surg. 2012, 143 (194): 194-200. Chang WK, Srinivasa S, MacCormick AD, Hill AG: Gentamicin-collagen implants to reduce surgical site infection: systematic review and meta-analysis of randomized trials. Ann Surg. 2013, 258 (1): 59-65. Jul Mavros MN, Mitsikostas PK, Alexiou VG, Peppas G, Falagas ME: Gentamicin collagen sponges for the prevention of sternal wound infection: a meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg. 2012, 144: 1235-1240. Popescu F, Rochon N, Raja S: Impact of Gentamicin – Collagen Sponge (Collatamp) on the incidence of sternal wound infection in high risk cardiac surgery patients. Journal of Cardiothoracic Surgery. 2013, 8 (Suppl 1): O123-